Skip to main content

Table 3 Results of adjusted models testing for differences in methylation variation

From: Association between acetaminophen metabolites and CYP2E1 DNA methylation level in neonate cord blood in the Boston Birth Cohort

CpG site

Sample variance

Log variance ratio

Difference in Levene’s Residuals

P-value (robust)

FDR

Genomic coordinate (GRCh37/hg19)

Gene Name

Feature categorya

Relation to CpG Island

cg24530264

0.888

− 0.303

− 0.179

2.70E04*

0.008

chr10:135342620

CYP2E1

Body

South Shore

cg18984983

1.004

− 0.364

− 0.168

9.94E04*

0.012

chr10:135342936

CYP2E1

Body

South Shore

cg00321709

1.115

− 0.260

− 0.180

1.58E03*

0.012

chr10:135341933

CYP2E1

Body

Island

cg03134882

0.805

− 0.145

− 0.126

1.68E03*

0.012

chr10:135341463

CYP2E1

Body

Island

cg19469447

1.296

− 0.142

− 0.140

4.07E03

0.023

chr10:135341870

CYP2E1

Body

Island

cg13315147

0.818

− 0.119

− 0.097

1.70E02

0.079

chr10:135341528

CYP2E1

Body

Island

cg05473257

1.327

− 0.116

− 0.108

2.69E02

0.108

chr10:135341443

CYP2E1

Body

Island

cg25330361

0.516

− 0.214

− 0.095

3.75E02

0.131

chr10:135342413

CYP2E1

Body

Island

cg23400446

1.423

− 0.090

− 0.090

1.00E01

0.312

chr10:135342560

CYP2E1

Body

Island

cg21024264

0.139

0.245

0.041

1.42E01

0.398

chr10:135341025

CYP2E1

1stExon

North Shore

cg26065573

0.081

− 0.241

− 0.028

1.64E01

0.410

chr10:135339469

CYP2E1

TSS1500

North Shore

cg09208540

0.034

0.162

0.019

1.76E01

0.410

chr10:135340467

CYP2E1

TSS1500

North Shore

cg07381788

0.063

− 0.121

− 0.021

2.58E01

0.555

chr10:135340445

CYP2E1

TSS1500

North Shore

cg11445109

1.201

− 0.144

− 0.074

3.12E01

0.595

chr10:135343248

CYP2E1

Body

South Shore

cg01355198

0.065

− 0.120

− 0.019

3.19E01

0.595

chr10:135347330

CYP2E1

Body

Open Sea

cg19837601

0.104

0.031

0.022

3.91E01

0.685

chr10:135340871

CYP2E1;CYP2E1

5'UTR;1stExon

North Shore

cg10862468

0.578

0.016

− 0.035

4.17E01

0.687

chr10:135342218

CYP2E1

Body

Island

cg05417377

0.074

0.100

0.015

4.42E01

0.687

chr10:135350807

CYP2E1

Body

Open Sea

cg08472147

0.046

− 0.070

− 0.011

5.04E01

0.719

chr10:135340583

CYP2E1

TSS1500

North Shore

cg10986462

0.241

0.068

− 0.031

5.14E01

0.719

chr10:135340539

CYP2E1

TSS1500

North Shore

cg00720244

0.063

− 0.114

− 0.010

5.93E01

0.790

chr10:135347434

CYP2E1

Body

Open Sea

cg19721068

0.107

− 0.440

− 0.011

6.81E01

0.867

chr10:135346592

CYP2E1

Body

Open Sea

cg14250048

0.115

− 0.225

0.007

7.84E01

0.954

chr10:135340785

CYP2E1

TSS200

North Shore

cg00436603

0.104

− 0.019

− 0.003

9.04E01

0.973

chr10:135340740

CYP2E1

TSS200

North Shore

cg16538390

0.038

0.098

− 0.001

9.35E01

0.973

chr10:135344917

CYP2E1

Body

South Shelf

cg19571004

0.162

0.076

− 0.002

9.46E01

0.973

chr10:135340850

CYP2E1

TSS200

North Shore

cg05194426

1.161

0.023

0.002

9.72E01

0.973

chr10:135343193

CYP2E1

Body

South Shore

cg01465364

0.113

− 0.006

0.001

9.73E01

0.973

chr10:135340721

CYP2E1

TSS200

North Shore

  1. Results are shown at each of the 28 CpGs located in CYP2E1, between participants with (n = 96) and without (n = 474) acetaminophen detection, sorted by P-value
  2. DNAm DNA methylation, FDR false discovery rate, chr chromosome. The P-values are the original P-values before adjustment for multiple testing. CpG sites with P-value < 1.79 × 10−3 (Bonferroni corrected threshold) were marked with asteroid (*). CpG sites with FDR < 0.05 were bolded. Covariates are child sex, delivery type, parity, gestational age, birthweight, maternal age, maternal marital status, prenatal smoking, prenatal alcohol use, intrauterine inflammation, preeclampsia, diabetes mellitus, maternal stress, estimated cell types and 2 surrogate variables. aGene feature category of CpG sites obtained from UCSC database: TSS, transcription start site; TSS200, 200 bases from TSS; TSS1500, 1500 bases from TSS; UTR, untranslated region